 |
| Author | Post |
|---|
Meg Mangin R.N.
Former Team Member
|
Posted: Wed Dec 15th, 2004 00:20 |
|
Inclusion criteria for study site counseling and participation in the ARF phase II clinical study of the Marshall Protocol
The Marshall Protocol (MP) is a very effective, curative treatment for many chronic diseases. However, not everyone with a qualifying disease is a candidate for the MP.
The MP has an excellent safety record but it is still an experimental treatment plan and the supervising doctor is responsible for the patient's well-being. Members should be aware there is a rare possibility that immunopathology will provoke a serious adverse event, especially if the disease process is well advanced.
The MP is relatively simple but very detailed. It must be followed correctly to ensure safety and success. Members (or their caregiver) must acquire a basic understanding of the scientific rationale and a thorough knowledge of their role in the recovery process.
Close monitoring and accurate counseling is important to ensure safety and success. That is best accomplished at this study site because no doctors are yet certified in the Marshall Protocol. This study site acts in an advisory capacity only.
Members must be under the care of a licensed health care provider. All guidance given on this study site is based on the understanding the supervising practitioner supports participation in the clinical study and has given permission to follow study site recommendations.
In order to receive counseling on this study site and be included in the cohort of study subjects, members (or their caregivers) must meet the following criteria:
-Acceptance of the seriousness of the diagnosis and symptoms.
-Acceptance of the validity of the Marshall pathogenesis.
-The desire to recover health instead of merely palliate symptoms.
-Access to, ability and willingness to use a computer to utilize the study site.
-Willingness to study the guideline/s of the MP and watch the DVDs.
-The ability to understand this information at a level that enables accurate follow through of directions.
-Willingness and ability to follow the MP exactly as recommended.
-Willingness to discontinue other protocol treatments and any contraindicated medications or supplements.
-An understanding and acceptance of the unavoidable immunopathology which will temporarily make symptoms worse and, in rare cases, may even cause an adverse event.
-An understanding that resolution of symptoms may take some time.
-A commitment to a lengthy treatment plan of several years or more.
-The ability to learn, early in the protocol, to independently manage immunopathology by adjusting MP medications so as to avoid taxing the resources of the study site moderators.
-A conviction you've chosen the correct treatment and a commitment strong enough to persist through any difficult adjustments and/or unpleasant immune system reactions.
-Willingness to post progress reports at appropriate intervals (weekly if inexperienced), volunteer pertinent, detailed information and answer all questions from the Moderators.
-The ability to comprehend Moderators' instructions and a willingness to follow Moderators' recommendations.
-The judgement to know when to ask for assistance on the study site.
-Finances to afford regular doctor visits, D-metabolites tests, Benicar, appropriate sunglasses, and MP antibiotics.
-Access to a doctor who will provide medical support, prescribe the MP medications and give permission to follow recommendations of the study site.
-Access to a reliable supply of Benicar (especially if it is not available in your country).
-Willingness to adapt your lifestyle to avoid sun/lights, including looking unconventional because you are covered from head to toe and wearing NoIR sunglasses indoors and out.
-Willingness to give up some foods, supplements and alternate treatments in order to avoid Vitamin D.
-If necessary, the capacity to avoid or limit sun/lights if still employed or responsible for raising children.
-A system of social support in place.
-Willingness to share all progress data, including all medical reports, when requested by Board Staff.
-Willingness to respond to periodic surveys that may be done for research purposes to assess response to treatment. (Please keep your email address in your profile current so you can be contacted.)
Note: The Marshall Protocol is contraindicated for pregnant women and nursing mothers. Women of childbearing age on the MP should take adequate contraceptive precautions.
An IMPORTANT SAFETY WARNING about the Marshall Protocol
Last edited on Tue Dec 23rd, 2008 10:28 by Dr Trevor Marshall
____________________
Nothing contained in this site is or should be considered, or used as a substitute for, medical advice, diagnosis or treatment by your physician.
|
Current time is 07:14 | |
|
|
|
|
